INDIA IPO
  • Home
  • About
    • About us
    • Our CSR
  • Services

    IPO

    • Initial Public Offering (IPO)
    • SME IPO Consultation
    • Mainline IPO Consultation
    • Follow-On Public Offer (FPO)
    • Pre-IPO Funding Consultants

    Capital Raising

    • Social Stock Exchange
    • Private Placement
    • Project Funding
    • REIT
    • SM REIT
    • Rights Issue Advisory
    • InvIT Rights Issue
    • InvIT Public Issue
    • InvIT Private Issue
    • Debt Syndication
    • Securitised Debt Instruments
    • Public Municipal Debt
    • Private Municipal Debt

    Finance Advisory

    • Business Valuation
    • Corporate Finance
    • Financial Modelling
    • Project Finance
  • Investors
  • Merchant Bankers

    SME

    • List of SME Merchant Bankers

    MAINBOARD

    • List of Mainboard Merchant Bankers
  • Resources

    Reports

    • Daily Reporter
    • IPO Calendar
    • Mainline IPO Report
    • SME IPO Report
    • SME IPOs by Sector
    • Mainboard IPOs by Sector

    IPO Knowledge

    • IPO World Magazine
    • IPO Process
    • Pre-IPO Process Guidance
    • IPO Blogs
    • Sector Wise IPO List In India
    • List of IPO Registrar

    Notifications / Circulars

    • BSE SME Eligibility Criteria
    • SEBI ICDR Amendment Regulations March 2025
    • SEBI SME IPO ICDR Amendments report Mar–Nov 2025
    • NSE Emerge Eligibility Criteria
    • ICDR
  • News/Updates
    • Markets & Money Update
    • IPO & Market Snaps
  • Contact Us
  • Check IPO Feasibility
Check IPO Feasibility
INDIA IPO
INDIA IPO

Contact Info:

  • +91-96506-37280
  • +011-47008280
  • info@indiaipo.in
  • 808, 8thFloor D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034.
shape
  1. Home
  2. News
  3. Aurobindo Pharma Shares In Focus On Buy Back Record Date
ipo services in India
India IPO
  • 17 Apr 2026
  • X
 Aurobindo Pharma Shares In Focus On Buy Back Record Date

Aurobindo Pharma will repurchase 54,23,728 fully paid-up equity shares, representing up to 0.93% stake, at a price of Rs 1,475 per share.

Aurobindo Pharma Shares In Focus On Buy Back Record Date

Aurobindo Pharma Ltd. shares will be in focus on Friday as the stock goes ex-trade for its proposed buy back of equity shares. The board has also set April 17 as the record date for the purpose of determining the entitlement and the names of equity shareholders who would be eligible to participate in the buyback.

The company will repurchase 54,23,728 fully paid-up equity shares, representing up to 0.93% stake, at a price of Rs 1,475 per share for an aggregate amount of Rs 800 crore.

The buy back is proposed to be made from all of the equity shareholders, including the promoters and members of the promoter group, on a proportionate basis through the “tender offer” route, according to a stock exchange filing said.

As of Dec. 31, 2025, promoters held 51.82% equity in Aurobindo Pharma, mutual funds 19.52%, insurance companies 5.5%, foreign portfolio investors 13.94% and retail investors 7.93%.

The company last repurchased shares from the market in July 2024.

ALSO READ: Wipro Announces Up To Rs 15,000 Crore Share Buyback — Check Per Share Repurchase Price, Other Details

Buyback Details

Eligible shareholders will receive a letter of offer through electronic mode only, within two working days from the record date, along with a Tender Offer form indicating the entitlement of the eligible shareholder for participating in the buyback. Even if the shareholder does not receive the Letter of Offer along with a tender form, he/she may participate and tender shares in the buyback.

The equity shares proposed to be bought back shall be divided into two categories: reserved category for small shareholders and general category for all other eligible shareholders.

A small shareholder is the one who holds equity shares whose market value, on the basis of the closing price on the exchanges having the highest trading volume as on the record date, is not more than Rs 2 lakh.

In accordance with regulation, 15% of the number of equity shares which the company proposes to buy back or the number of Equity Shares entitled as per the shareholding of Small Shareholders as on the Record Date, whichever is higher, shall be reserved for the Small Shareholders as part of this Buyback.

Taxation

Starting this month, the shareholder is responsible for paying the capital gains tax on share buy backs. The amount an investor receives is treated as capital gains, and he/she can deduct the cost of acquiring the tendered stocks from the buyback proceeds. The applicable tax rate depends on how long the investor held the stocks:

Long-term (held for more than 12 months): 12.5% capital gains tax.

Short-term (held for 12 months or less): 20% capital gains tax.

Companies pay 20% on the distributed income for non-promoters, while promoters face higher taxes.

ALSO READ: Wipro's Rs 15,000-Crore Buyback: How Retail Investors Will Be Impacted By Promoters' Participation

Recent News

Indian markets open lower amid cautious sentiment; global cues mixed on ceasefire news
Indian markets open lower amid cautious sentiment; global cu...
17 Apr 2026
Indian stock markets gain in early trade amid oil relief, Israel
Indian stock markets gain in early trade amid oil relief, Is...
17 Apr 2026
Best aggressive hybrid mutual funds to invest in April 2026
Best aggressive hybrid mutual funds to invest in April 2026
17 Apr 2026
Wipro final dividend 2026 for FY26: Here's what you need to know
Wipro final dividend 2026 for FY26: Here's what you need to...
17 Apr 2026
OpenAI's $20 Billion Bet on Cerebras Chips Signals Major AI Race Moves
OpenAI's $20 Billion Bet on Cerebras Chips Signals Major AI...
17 Apr 2026
OpenAI to spend more than $20 billion on Cerebras chips, receive equity stake: The Information
OpenAI to spend more than $20 billion on Cerebras chips, rec...
17 Apr 2026
OpenAI to spend more than $20 billion on Cerebras chips, receive equity stake: Report
OpenAI to spend more than $20 billion on Cerebras chips, rec...
17 Apr 2026
Mehul Telecom IPO opens for subscription. Check GMP, price band, and other details
Mehul Telecom IPO opens for subscription. Check GMP, price b...
17 Apr 2026
Citius Transnet InvIT IPO opens today. Check price band, subscription and other details
Citius Transnet InvIT IPO opens today. Check price band, sub...
17 Apr 2026
Sam Altman’s side hustles blur the line between OpenAI’s interests and his own
Sam Altman’s side hustles blur the line between OpenAI’s int...
17 Apr 2026
pre ipo advisory services in India
  • GST No: 07AAHCB7068H2ZF

India IPO is a leading Indian business services platform that helps firms and companies to launch their initial public offerings (IPOs) in order to raise essential capital for growth and expansion while adding value & fueling the nation’s immense potential and future opportunities.

Follow us:

Facebook Twitter LinkedIn Instagram YouTube

Quick Links

  • Home
  • Blogs
  • Consultant
  • Youtube Videos
  • News
  • Contact Us
  • Career

Contact Information:

  • Corporate Office: 808, 8th Floor, D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034
  • Regional Office: Office No. 601, Shagun Insignia, Ulwe, Sector-19, Navi Mumbai- 410206
  • Email: info@indiaipo.in
  • Mobile: +91-74283-37280, +91-96509-82781
  • Disclaimer  |
  • Privacy & Policy  |
  • Terms & Conditions  

Copyright © All rights reserved by - Bmarkt Tecamat Private Limited